Geneve
Switzerland
2
2021-05-06
2
2023-01-24
These are the the leading inventors for applications assigned to CELL RECEPTOR AG:
CELL RECEPTOR AG based in Geneve, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Combination of a MAPK/ERK pathway inhibitor and a glycosaminoglycan for the treatment of cancer
#2 | 2016-12-22 ✅ Patent 10,098,906 granted on 2018-10-16Modulation of the physical interaction between platelets and the cell surface effecting cell proliferation
310033 ⎘